NYSE:ABBV - AbbVie Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $121.67
Forecasted Upside: 3.15 %
Number of Analysts: 14
Breakdown:
1 Sell Ratings
1 Hold Ratings
12 Buy Ratings
0 Strong Buy Ratings

^$117.96 As of 07/27/2021 01:00 AM ET

▲ +0.17 (0.14%)

1 month | 3 months | 12 months

Get New AbbVie Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for ABBV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ABBV

^$121.67

▲ +3.15% Upside Potential

This price target is based on 14 analysts offering 12 month price targets for AbbVie in the last 3 months. The average price target is $121.67, with a high forecast of $144.00 and a low forecast of $98.00. The average price target represents a 3.15% upside from the last price of $117.96.

Current Consensus is Buy

The current consensus among 14 polled investment analysts is to buy stock in AbbVie. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations Description Skip Past Price Target Consensus Chart

0 strong buy ratings
9 buy ratings
2 hold ratings
2 sell ratings

Ratings as of

2/4/2020

0 strong buy ratings
9 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

5/4/2020

0 strong buy ratings
14 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

8/2/2020

0 strong buy ratings
14 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

10/31/2020

0 strong buy ratings
16 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

1/29/2021

0 strong buy ratings
13 buy ratings
2 hold ratings
1 sell ratings

Ratings as of

4/29/2021

0 strong buy ratings
10 buy ratings
1 hold ratings
1 sell ratings

Ratings as of

6/28/2021

0 strong buy ratings
12 buy ratings
1 hold ratings
1 sell ratings

Ratings as of

7/28/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
7/27/2021	Truist Securities	Initiated Coverage	Buy	$117.00	Low
7/27/2021	Truist	Initiated Coverage	Buy	$118.00 ➝ $124.08	Low
7/2/2021	Daiwa Capital Markets	Initiated Coverage	Outperform		Low
5/3/2021	BMO Capital Markets	Boost Price Target	Outperform	$127.00 ➝ $129.00	High
5/3/2021	Mizuho	Boost Price Target	Buy	$126.00 ➝ $128.00	High
4/30/2021	Piper Sandler	Boost Price Target	Overweight	$120.00 ➝ $124.00	Low
4/7/2021	Royal Bank of Canada	Initiated Coverage		$135.00	Low
3/30/2021	SVB Leerink	Boost Price Target	Outperform	$140.00 ➝ $144.00	Low
2/4/2021	SVB Leerink	Boost Price Target	In-Line ➝ Outperform	$128.00 ➝ $140.00	Low
2/4/2021	Royal Bank of Canada	Boost Price Target	Outperform	$129.00 ➝ $135.00	Low
2/4/2021	Mizuho	Boost Price Target	Buy	$117.00 ➝ $126.00	Low
1/28/2021	Morgan Stanley	Lower Price Target	Overweight	$120.00 ➝ $116.00	Medium
12/16/2020	SVB Leerink	Boost Price Target	Outperform	$119.00 ➝ $128.00	Medium
12/15/2020	Mizuho	Boost Price Target		$111.00 ➝ $117.00	Medium
11/30/2020	Morgan Stanley	Boost Price Target	Positive ➝ Overweight	$108.00 ➝ $120.00	Low
11/18/2020	BMO Capital Markets	Initiated Coverage	Outperform	$123.00 ➝ $123.00	Medium
11/10/2020	Sanford C. Bernstein	Initiated Coverage	Outperform	$120.00	High
11/2/2020	SVB Leerink	Lower Price Target	Outperform	$122.00 ➝ $119.00	High
10/23/2020	Truist	Initiated Coverage	Buy	$110.00	Low
10/20/2020	The Goldman Sachs Group	Downgrade	Neutral ➝ Sell		High
10/16/2020	JPMorgan Chase & Co.	Boost Price Target	Overweight	$115.00 ➝ $120.00	Low
9/29/2020	Berenberg Bank	Initiated Coverage	Hold	$98.00	Low
9/27/2020	Mizuho	Reiterated Rating	Buy	$111.00	Low
9/2/2020	Citigroup	Boost Price Target	Buy	$98.00 ➝ $105.00	Medium
8/20/2020	Morgan Stanley	Boost Price Target	Overweight	$95.00 ➝ $108.00	Medium
8/3/2020	Mizuho	Boost Price Target	Buy	$110.00 ➝ $111.00	Low
8/3/2020	Royal Bank of Canada	Boost Price Target	Outperform	$125.00 ➝ $127.00	Low
6/29/2020	Mizuho	Boost Price Target	Top Pick ➝ Buy	$101.00 ➝ $110.00	Low
6/25/2020	Royal Bank of Canada	Boost Price Target	Outperform	$102.00 ➝ $125.00	Medium
6/23/2020	Atlantic Securities	Upgrade	Neutral ➝ Overweight	$115.00	Medium
6/18/2020	Royal Bank of Canada	Reiterated Rating	Buy	$102.00	Low
6/17/2020	UBS Group	Boost Price Target		$96.00 ➝ $109.00	Low
6/10/2020	Evercore ISI	Initiated Coverage	Buy	$111.00	High
6/10/2020	Piper Sandler	Boost Price Target		$97.00 ➝ $110.00	High
6/9/2020	Wolfe Research	Upgrade	Peer Perform ➝ Outperform		Low
6/2/2020	Argus	Upgrade	Hold ➝ Buy	$91.40 ➝ $115.00	Low
5/28/2020	Royal Bank of Canada	Reiterated Rating	Buy	$102.00	Low
5/18/2020	Bank of America	Initiated Coverage	Neutral	$95.00	Low
5/12/2020	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$105.00	Medium
5/11/2020	Morgan Stanley	Reiterated Rating	Overweight	$95.00	High
5/11/2020	SVB Leerink	Boost Price Target	Outperform	$107.00 ➝ $122.00	High
5/4/2020	SVB Leerink	Boost Price Target	Outperform	$103.00 ➝ $107.00	Low
5/1/2020	Mizuho	Reiterated Rating	Buy	$100.00	Medium
4/20/2020	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$79.00 ➝ $93.00	Low
4/13/2020	UBS Group	Lower Price Target	Buy	$106.00 ➝ $96.00	Low
4/12/2020	Royal Bank of Canada	Reiterated Rating	Hold	$79.00	Low
3/23/2020	Societe Generale	Downgrade	Buy ➝ Hold		High
2/27/2020	Barclays	Initiated Coverage	Equal Weight	$97.00 ➝ $97.00	High
2/18/2020	Cowen	Boost Price Target	Outperform	$98.00 ➝ $105.00	Low
2/10/2020	Mizuho	Boost Price Target		$96.00 ➝ $104.00	High
2/7/2020	Piper Sandler	Boost Price Target	Overweight	$95.00 ➝ $97.00	Low
2/5/2020	Mizuho	Initiated Coverage	Buy	$96.00 ➝ $96.00	Low
1/23/2020	Royal Bank of Canada	Reiterated Rating	Hold	$86.00	High
1/6/2020	Royal Bank of Canada	Initiated Coverage	Sector Perform	$86.00	Low
1/3/2020	Bank of America	Downgrade	Buy ➝ Neutral		Low
12/26/2019	Cowen	Boost Price Target	Outperform	$90.00 ➝ $98.00	Low
11/20/2019	Citigroup	Boost Price Target	Buy	$90.00 ➝ $98.00	Medium
11/19/2019	UBS Group	Boost Price Target	Buy	$79.00 ➝ $96.00	High
11/1/2019	Piper Jaffray Companies	Boost Price Target		$81.00 ➝ $90.00	High
9/26/2019	Citigroup	Upgrade	Neutral ➝ Buy	$87.00 ➝ $90.00	Medium
9/24/2019	Cowen	Set Price Target	Buy	$90.00	Low
9/12/2019	UBS Group	Upgrade	Neutral ➝ Buy	$85.00 ➝ $79.00	Low
9/4/2019	Piper Jaffray Companies	Boost Price Target	Overweight	$80.00 ➝ $81.00	Medium
8/20/2019	Piper Jaffray Companies	Upgrade	Neutral ➝ Overweight	$80.00	High
7/26/2019	Piper Jaffray Companies	Set Price Target	Hold	$80.00	N/A
7/2/2019	SVB Leerink	Upgrade	Buy		Low
6/27/2019	Wolfe Research	Upgrade	Underperform ➝ Peer Perform		Medium
6/26/2019	Citigroup	Reiterated Rating	Hold		Medium
6/26/2019	SVB Leerink	Upgrade	Market Perform ➝ Outperform	$88.00	High
5/28/2019	The Goldman Sachs Group	Initiated Coverage	Neutral ➝ Neutral	$84.00	High
4/28/2019	BMO Capital Markets	Upgrade	Underperform ➝ Market Perform	$71.00 ➝ $79.00	Low
4/26/2019	Credit Suisse Group	Set Price Target	Sell	$78.00	Low
3/25/2019	Argus	Downgrade	Buy ➝ Hold		Low
2/14/2019	Barclays	Reiterated Rating	Hold	$86.00	Low
1/25/2019	Credit Suisse Group	Set Price Target	Hold	$79.00	High
1/23/2019	UBS Group	Reiterated Rating	Neutral ➝ Neutral	$97.00 ➝ $91.00	Low
1/17/2019	Credit Suisse Group	Upgrade	Hold	$79.00	Medium
1/3/2019	Bank of America	Downgrade	Buy ➝ Neutral		Medium
12/26/2018	Standpoint Research	Initiated Coverage	Buy ➝ Buy		High
12/20/2018	Morgan Stanley	Set Price Target	Hold	$88.00	High
11/6/2018	Argus	Lower Price Target	Buy ➝ Buy	$130.00 ➝ $115.00	Low
11/5/2018	BMO Capital Markets	Lower Price Target	Underperform ➝ Underperform	$78.00 ➝ $71.00	Low
11/4/2018	Barclays	Reiterated Rating	Hold	$90.00	High
11/2/2018	Credit Suisse Group	Set Price Target	Hold	$85.00	High
10/23/2018	Wolfe Research	Initiated Coverage	Underperform		Low
10/22/2018	SunTrust Banks	Lower Price Target	Buy ➝ Buy	$157.00 ➝ $135.00	High
10/20/2018	Credit Suisse Group	Set Price Target	Sell	$85.00	High
10/14/2018	Credit Suisse Group	Set Price Target	Hold	$85.00	Medium
10/4/2018	Bank of America	Lower Price Target	Buy ➝ Buy	$107.00 ➝ $106.00	Medium
8/22/2018	Bank of America	Boost Price Target	Buy ➝ Buy	$105.00 ➝ $107.00	Low
8/22/2018	BMO Capital Markets	Reiterated Rating	Sell	$78.00	Low
7/30/2018	Bank of America	Lower Price Target	Buy ➝ Buy	$112.00 ➝ $105.00	Medium
7/27/2018	Piper Jaffray Companies	Reiterated Rating	Hold	$100.00	Low
7/27/2018	Cowen	Set Price Target	Buy	$110.00	Low
7/27/2018	BMO Capital Markets	Reiterated Rating	Sell	$78.00	Low
7/15/2018	Jefferies Financial Group	Set Price Target	Buy	$100.00	Low
7/13/2018	Credit Suisse Group	Upgrade	Hold	$89.00	Low
7/12/2018	Berenberg Bank	Initiated Coverage	Hold	$105.00	Low
6/11/2018	Argus	Lower Price Target	Buy ➝ Buy	$145.00 ➝ $130.00	Low
6/6/2018	Credit Suisse Group	Set Price Target	Sell	$89.00	Low
6/1/2018	Piper Jaffray Companies	Downgrade	Overweight ➝ Neutral	$125.86 ➝ $66.62	Low
5/30/2018	Deutsche Bank Aktiengesellschaft	Downgrade	Neutral ➝ Underperform	$125.86 ➝ $65.61	Medium
5/30/2018	Deutsche Bank Aktiengesellschaft	Downgrade	Neutral ➝ Underperform	$125.86 ➝ $65.61	Low
5/29/2018	Credit Suisse Group	Downgrade	Neutral ➝ Sell	$104.00 ➝ $89.00	Medium
5/24/2018	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy		High
5/23/2018	BMO Capital Markets	Lower Price Target	Underperform ➝ Underperform	$81.00 ➝ $78.00	Low
5/1/2018	BMO Capital Markets	Reiterated Rating	Sell	$81.00	Low
4/30/2018	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$131.00 ➝ $110.00	High
4/27/2018	Credit Suisse Group	Lower Price Target	Neutral ➝ Neutral	$109.00 ➝ $104.00	Medium
4/22/2018	Credit Suisse Group	Set Price Target	Hold	$109.00	Low
4/13/2018	Jefferies Financial Group	Set Price Target	Buy	$122.00	Low
4/10/2018	Credit Suisse Group	Set Price Target	Hold	$109.00	Low
4/5/2018	Barclays	Lower Price Target	Equal Weight ➝ Equal Weight	$120.00 ➝ $102.00	Low
4/5/2018	BMO Capital Markets	Reiterated Rating	Sell	$80.00	Low
3/26/2018	Bank of America	Set Price Target	Hold	$120.00	High
3/23/2018	Jefferies Financial Group	Set Price Target	Buy	$125.00	High
3/23/2018	Credit Suisse Group	Lower Price Target	Neutral	$109.00 ➝ $98.10	Medium
3/23/2018	BMO Capital Markets	Lower Price Target	Underperform ➝ Underperform	$95.00 ➝ $80.00	Medium
3/22/2018	BMO Capital Markets	Set Price Target	Sell	$95.00	High
3/13/2018	BMO Capital Markets	Set Price Target	Sell	$95.00	Low
2/26/2018	Jefferies Financial Group	Set Price Target	Buy	$145.00	Low
2/21/2018	BMO Capital Markets	Set Price Target	Sell	$95.00	Low
2/15/2018	BMO Capital Markets	Reiterated Rating	Sell	$95.00	High
2/15/2018	Piper Jaffray Companies	Boost Price Target	Overweight	$130.00 ➝ $138.00	High
2/2/2018	Argus	Boost Price Target	Buy	$120.00 ➝ $145.00	Low
1/30/2018	Morgan Stanley	Boost Price Target	Equal Weight ➝ Equal Weight	$99.00 ➝ $131.00	Low
1/29/2018	Evercore ISI	Reiterated Rating	Buy	$144.00	Low
1/29/2018	Credit Suisse Group	Set Price Target	Hold	$98.00 ➝ $135.00	Medium
1/29/2018	BMO Capital Markets	Downgrade	Market Perform ➝ Underperform	$125.86 ➝ $84.00	Low
1/29/2018	SunTrust Banks	Boost Price Target	Buy ➝ Average	$157.00	Low
1/29/2018	SVB Leerink	Downgrade	Outperform ➝ Market Perform	$127.00	Medium
1/26/2018	Piper Jaffray Companies	Boost Price Target	Outperform	$115.00 ➝ $130.00	Low
1/22/2018	Credit Suisse Group	Set Price Target	Hold	$98.00	Low
1/11/2018	BMO Capital Markets	Set Price Target	Hold	$84.00	Low
1/4/2018	Jefferies Financial Group	Boost Price Target	Buy	$115.00 ➝ $120.00	Low
1/2/2018	Piper Jaffray Companies	Reiterated Rating	Buy		High
12/20/2017	BMO Capital Markets	Set Price Target	Hold	$84.00	Medium
12/5/2017	SVB Leerink	Set Price Target	Buy	$106.00	Low
12/4/2017	BMO Capital Markets	Set Price Target	Hold	$84.00	Low
11/21/2017	BMO Capital Markets	Reiterated Rating	Hold	$84.00	N/A
11/21/2017	Societe Generale	Boost Price Target			N/A
10/30/2017	SunTrust Banks	Reiterated Rating	Buy		N/A
10/30/2017	SVB Leerink	Lower Price Target	Outperform	$108.00 ➝ $107.00	N/A
10/27/2017	BMO Capital Markets	Set Price Target	Hold	$66.00	N/A
10/27/2017	Piper Jaffray Companies	Boost Price Target	Overweight	$115.00	N/A
10/16/2017	Jefferies Financial Group	Boost Price Target	Buy	$107.00 ➝ $115.00	N/A
10/13/2017	Barclays	Boost Price Target	Equal Weight	$90.00	N/A
10/13/2017	UBS Group	Reiterated Rating	Neutral		N/A
10/11/2017	Cowen	Upgrade	Market Perform ➝ Outperform	$91.17 ➝ $105.00	N/A
10/2/2017	SVB Leerink	Upgrade	Market Perform ➝ Outperform	$89.00 ➝ $106.00	Medium
10/1/2017	Credit Suisse Group	Reiterated Rating	Neutral	$74.00 ➝ $94.00	Medium
9/30/2017	Evercore ISI	Reiterated Rating	Outperform	$95.00 ➝ $100.00	Medium
9/29/2017	Argus	Boost Price Target	Buy	$90.00 ➝ $110.00	Low
9/29/2017	Morgan Stanley	Boost Price Target	Equal Weight	$70.00 ➝ $95.00	Low
9/28/2017	Barclays	Reiterated Rating	Hold	$68.00	Low
9/28/2017	BMO Capital Markets	Reiterated Rating	Hold	$66.00	Low
9/28/2017	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$88.00	Low
9/28/2017	Jefferies Financial Group	Reiterated Rating	Buy	$107.00	Medium
9/25/2017	UBS Group	Downgrade	Buy ➝ Neutral	$79.00 ➝ $92.00	Low
9/15/2017	Jefferies Financial Group	Reiterated Rating	Buy ➝ Buy	$94.00 ➝ $107.00	High
9/15/2017	Piper Jaffray Companies	Reiterated Rating	Buy	$100.00	High
9/13/2017	SunTrust Banks	Reiterated Rating	Buy	$95.00	Low
9/12/2017	SVB Leerink	Reiterated Rating	Market Perform		Low
9/11/2017	Cowen	Reiterated Rating	Market Perform ➝ Hold	$70.00 ➝ $95.00	Medium
9/8/2017	The Goldman Sachs Group	Reiterated Rating	Buy	$85.00 ➝ $100.00	Low
9/8/2017	Jefferies Financial Group	Reiterated Rating	Buy	$94.00	Low
8/16/2017	Evercore ISI	Initiated Coverage	Outperform ➝ Outperform	$95.00	Medium
8/3/2017	Piper Jaffray Companies	Reiterated Rating	Buy	$85.00	Low
7/30/2017	Cowen	Set Price Target	Hold	$70.00	Low
7/20/2017	Credit Suisse Group	Reiterated Rating	Neutral	$65.00 ➝ $74.00	Medium
7/17/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Hold	$65.00 ➝ $66.00	Low
7/17/2017	Jefferies Financial Group	Reiterated Rating	Buy	$92.00 ➝ $94.00	Low
6/22/2017	SVB Leerink	Reiterated Rating	Market Perform		Low
6/22/2017	Societe Generale	Upgrade	Hold ➝ Buy		Low
6/7/2017	Credit Suisse Group	Reiterated Rating	Hold	$65.00	Medium
5/26/2017	Jefferies Financial Group	Reiterated Rating	Buy		N/A
5/17/2017	BMO Capital Markets	Reiterated Rating	Market Perform	$66.00	Low
5/2/2017	BMO Capital Markets	Boost Price Target	Market Perform	$63.00 ➝ $66.00	Low
4/28/2017	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$64.00 ➝ $65.00	Low
4/27/2017	BMO Capital Markets	Set Price Target	Hold	$63.00	Medium
4/20/2017	SVB Leerink	Set Price Target	Hold	$71.00	Low
4/18/2017	BMO Capital Markets	Reiterated Rating	Hold	$63.00	Low
3/22/2017	Societe Generale	Upgrade	Sell ➝ Hold		Low
3/22/2017	BMO Capital Markets	Reiterated Rating	Hold	$63.00	Low
3/11/2017	The Goldman Sachs Group	Upgrade	Buy ➝ Conviction-Buy	$74.00 ➝ $80.00	N/A
3/7/2017	Jefferies Financial Group	Reiterated Rating	Top Pick ➝ Buy	$4.30 ➝ $90.00	N/A
2/14/2017	Jefferies Financial Group	Reiterated Rating	Buy	$90.00	N/A
1/5/2017	Jefferies Financial Group	Reiterated Rating	Buy	$90.00	N/A
12/8/2016	William Blair	Reiterated Rating	Outperform	$76.00	N/A
11/28/2016	Citigroup	Downgrade	Buy ➝ Neutral	$60.00	N/A
11/8/2016	SVB Leerink	Reiterated Rating	Hold		N/A
11/8/2016	BMO Capital Markets	Reiterated Rating	Market Perform	$63.00	N/A
11/8/2016	Citigroup	Reiterated Rating	Buy		N/A
11/1/2016	Jefferies Financial Group	Reiterated Rating	Buy	$90.00	N/A
10/31/2016	Credit Suisse Group	Downgrade	Outperform ➝ Neutral	$70.00 ➝ $60.00	N/A
10/18/2016	SVB Leerink	Initiated Coverage	Market Perform	$70.00	N/A
10/5/2016	Jefferies Financial Group	Reiterated Rating	Buy	$90.00	N/A
9/27/2016	The Goldman Sachs Group	Reiterated Rating	Buy	$78.00	N/A
9/8/2016	The Goldman Sachs Group	Reiterated Rating	Buy	$78.00	N/A
9/8/2016	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$75.00 ➝ $73.00	N/A
9/7/2016	UBS Group	Reiterated Rating	Buy		N/A
9/1/2016	Raymond James	Initiated Coverage	Outperform	$82.00	N/A
8/25/2016	Jefferies Financial Group	Reiterated Rating	Buy		N/A
8/8/2016	Argus	Reiterated Rating	Buy	$85.00	N/A
8/4/2016	Jefferies Financial Group	Reiterated Rating	Buy		N/A
8/2/2016	Barclays	Reiterated Rating	Equal Weight	$68.00	N/A
7/29/2016	BMO Capital Markets	Reiterated Rating	Market Perform	$66.00	N/A

(Data available from 7/28/2016 forward)

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Today's Range

Now: $117.96

$116.76

$118.30

50 Day Range

MA: $115.07

$111.40

$118.19

52 Week Range

Now: $117.96

$79.11

$118.67

Volume

3,731,599 shs

Average Volume

5,399,075 shs

Market Capitalization

$208.34 billion

P/E Ratio

41.68

Dividend Yield

4.41%

Beta

0.83

Frequently Asked Questions

What sell-side analysts currently cover shares of AbbVie?

The following sell-side analysts have issued research reports on AbbVie in the last year: Berenberg Bank, BMO Capital Markets, Citigroup Inc., Daiwa Capital Markets, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Piper Sandler, Royal Bank of Canada, Sanford C. Bernstein, SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist, Truist Securities, and Zacks Investment Research.
View the latest analyst ratings for ABBV.

What is the current price target for AbbVie?

12 Wall Street analysts have set twelve-month price targets for AbbVie in the last year. Their average twelve-month price target is $121.67, suggesting a possible upside of 3.1%. SVB Leerink LLC has the highest price target set, predicting ABBV will reach $144.00 in the next twelve months. Berenberg Bank has the lowest price target set, forecasting a price of $98.00 for AbbVie in the next year.
View the latest price targets for ABBV.

What is the current consensus analyst rating for AbbVie?

AbbVie currently has 1 sell rating, 1 hold rating and 12 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ABBV will outperform the market and that investors should add to their positions of AbbVie.
View the latest ratings for ABBV.

What other companies compete with AbbVie?

Other companies that are similar to AbbVie include Johnson & Johnson, Pfizer, Eli Lilly and, Merck & Co., Inc., Bristol-Myers Squibb, Zoetis, Royalty Pharma, Horizon Therapeutics Public, Jazz Pharmaceuticals, Perrigo, Nektar Therapeutics, Pacira BioSciences, Corcept Therapeutics, Supernus Pharmaceuticals and Endo International.

How do I contact AbbVie's investor relations team?

AbbVie's physical mailing address is 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL, 60064. The company's listed phone number is (847) 932-7900. The official website for AbbVie is www.abbvie.com.